| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LMNB1 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | KRT18 | CTRPv2 | pan-cancer | AAC | -0.21 | 4e-10 |
| mRNA | LIN9 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-10 |
| mRNA | EHMT2 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-10 |
| mRNA | SNRPD1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-10 |
| mRNA | CAD | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-10 |
| mRNA | ZBED4 | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-10 |
| mRNA | UBTF | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-10 |
| mRNA | HNRNPA1 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-10 |
| mRNA | CHAF1B | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-10 |
